Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$13.90
Change (%) Stock is Up 0.15 (1.09%)
Volume1,649,416
Data as of 02/24/17 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
02/16/17
Download Documentation Company Update (February)

Recent News

More >>
DateTitle 
02/24/17Heron Therapeutics Announces Inclusion of SUSTOL® (Granisetron) Extended-Release Injection in NCCN® Antiemesis GuidelinesPrinter Friendly Version
02/23/17Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate ProgressPrinter Friendly Version
02/08/17Heron Therapeutics to Present at the Leerink Partners 6th Annual Global Healthcare ConferencePrinter Friendly Version
01/31/17Heron Therapeutics Announces Underwriters’ Exercise in Full of Option to Purchase Additional SharesPrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.